NO941562L - Use of Brandykinin Anatonist for the Preparation of a Medication for Prophylaxis or Pre-Treatment of Arteriosclerosis - Google Patents

Use of Brandykinin Anatonist for the Preparation of a Medication for Prophylaxis or Pre-Treatment of Arteriosclerosis

Info

Publication number
NO941562L
NO941562L NO941562A NO941562A NO941562L NO 941562 L NO941562 L NO 941562L NO 941562 A NO941562 A NO 941562A NO 941562 A NO941562 A NO 941562A NO 941562 L NO941562 L NO 941562L
Authority
NO
Norway
Prior art keywords
arteriosclerosis
prophylaxis
treatment
anatonist
brandykinin
Prior art date
Application number
NO941562A
Other languages
Norwegian (no)
Other versions
NO941562D0 (en
Inventor
Wolfgang Linz
Klaus Wirth
Bernward Scholkens
Gerhard Breipohl
Stephan Henke
Jochen Knolle
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO941562D0 publication Critical patent/NO941562D0/no
Publication of NO941562L publication Critical patent/NO941562L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Anvendelse av bradykinin-antagonister for profylakse og for behandling av arteriosklerose er beskrevet. De anvendte bradykinin antagonistene har et innhold av aminosyrene D-Tlc, D-Phe, D-Dic, D-Thi eller D-Nal i posisjon 7 til peptidet.Use of bradykinin antagonists for prophylaxis and for the treatment of arteriosclerosis is described. The bradykinin antagonists used have a content of amino acids D-Tlc, D-Phe, D-Dic, D-Thi or D-Nal at position 7 of the peptide.

NO941562A 1993-04-29 1994-04-28 Use of Brandykinin Anatonist for the Preparation of a Medication for Prophylaxis or Pre-Treatment of Arteriosclerosis NO941562L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4314073 1993-04-29

Publications (2)

Publication Number Publication Date
NO941562D0 NO941562D0 (en) 1994-04-28
NO941562L true NO941562L (en) 1994-10-31

Family

ID=6486700

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941562A NO941562L (en) 1993-04-29 1994-04-28 Use of Brandykinin Anatonist for the Preparation of a Medication for Prophylaxis or Pre-Treatment of Arteriosclerosis

Country Status (8)

Country Link
EP (1) EP0623350A1 (en)
JP (1) JPH06312940A (en)
AU (1) AU677290B2 (en)
CA (1) CA2122429A1 (en)
HU (1) HUT66820A (en)
IL (1) IL109447A0 (en)
NO (1) NO941562L (en)
TW (1) TW301608B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739553B1 (en) * 1995-10-06 1998-01-02 Oreal USE OF BRADYKININE ANTAGONISTS TO STIMULATE OR INDUCE HAIR GROWTH AND / OR STOP THE HAIR LOSS
US9492495B2 (en) 2010-05-14 2016-11-15 Max-Delbrueck-Centrum Fuer Molekulare Medizin Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth
EP2420245A1 (en) * 2010-08-18 2012-02-22 Max-Delbrück-Centrum Für Molekulare Medizin Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth
CN103992383B (en) * 2014-06-27 2017-05-17 杭州阿诺生物医药科技股份有限公司 Method for preparing icatibant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3604873A1 (en) * 1986-02-15 1987-08-20 Basf Ag METHOD FOR PRODUCING 2,6-BIS (HYDROXYMETHYL) -PYRIDINE-2,6-BIS- (N-METHYLCARBAMATE)

Also Published As

Publication number Publication date
EP0623350A1 (en) 1994-11-09
AU677290B2 (en) 1997-04-17
HU9401226D0 (en) 1994-08-29
AU6073794A (en) 1994-11-03
HUT66820A (en) 1995-01-30
CA2122429A1 (en) 1994-10-30
NO941562D0 (en) 1994-04-28
JPH06312940A (en) 1994-11-08
IL109447A0 (en) 1994-07-31
TW301608B (en) 1997-04-01

Similar Documents

Publication Publication Date Title
DE3889536D1 (en) TREATING CANCER WITH SOMATOSTATIN AND WITH ANALOGS OF IT.
ATE280826T1 (en) CC CHEMOKINCEPTOR C-C CKR-5, DERIVATIVES THEREOF AND USES
ATE338771T1 (en) ANTAGONISTS OF THE INTESTINOTROPH GLP-2 PEPTIDE
DE69417252D1 (en) IMPROVED IMMUNOGENIC COMPOSITION AGAINST HUMAN GASTRIN 17
DK289285D0 (en) THYMOPENTIN ANALOGUE
HUP0000432A2 (en) Insulin c-peptides
TR199802534T2 (en) Leptin (OB Protein) fragmanlar�
NO873699D0 (en) POLYPEPTIDE SUITABLE FOR DIMENSION, TREATMENT AND DIAGNOSIS OF AUTOIMMUNE DISEASES SUCH AS ARTICLES.
ATE280777T1 (en) BRADYKININ ANTAGONIST PEPTIDES WITH N-SUBSTITUTED GLYCINES
SE9101838D0 (en) NOVEL PEPTIDES AND THEIR USE
ATE111484T1 (en) THROMBOSIS PREVENTION COMPOUNDS.
AU682166B2 (en) Synergising association having an antagonist effect on NK1 and NK2 receptors
HUP9901353A2 (en) Use of an ace-inhibitor for producing pharmaceutical composition suitable for treating dyspeptic symptoms
NO941562L (en) Use of Brandykinin Anatonist for the Preparation of a Medication for Prophylaxis or Pre-Treatment of Arteriosclerosis
AU682638B2 (en) Peptide, bronchodilator and blood flow ameliorant
ATE42308T1 (en) PHARMACOLOGICALLY ACTIVE PEPTIDES.
DE69002881D1 (en) Peptides and their use.
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
UA41881C2 (en) Drug for treating or preventing inflammation and method for treating or preventing inflammation (variants)
MX9205978A (en) NEW TOMB INHIBITOR PROTEINS OF TICKS.
SE8800461L (en) PHARMACEUTICAL COMPOSITION
ATE92078T1 (en) PHARMACOLOGICALLY ACTIVE PEPTIDES.
DK0792291T3 (en) Protein affecting KATP channels
KR950704358A (en) Cathepsin L specific inhibitory polypeptide
DE3665462D1 (en) Pharmacologically active peptides